FB2026_01 , released March 12, 2026
FB2026_01 , released March 12, 2026
Allele: Dmel\Act57BE84K
Open Close
General Information
Symbol
Dmel\Act57BE84K
Species
D. melanogaster
Name
FlyBase ID
FBal0298403
Feature type
allele
Associated gene
Associated Insertion(s)
Carried in Construct
Key Links
Genomic Maps

Allele class
Nature of the Allele
Allele class
Progenitor genotype
Cytology
Description

Amino acid replacement: E84K.

Sequence analysis reveals a point mutation of the highly conserved residue glutamate 84 to lysine (E84K) in Act57BE84K.

Mutations Mapped to the Genome
Curation Data
Type
Location
Additional Notes
References
Nucleotide change:

G20945053A

Amino acid change:

E84K | Act57B-PA

Reported amino acid change:

E84K

Comment:

Site of nucleotide substitution in mutant inferred by FlyBase based on reported amino acid change.

Variant Molecular Consequences
Associated Sequence Data
DNA sequence
Protein sequence
 
Expression Data
Reporter Expression
Additional Information
Statement
Reference
 
Marker for
Reflects expression of
Reporter construct used in assay
Human Disease Associations
Disease Ontology (DO) Annotations
Models Based on Experimental Evidence ( 0 )
Disease
Evidence
References
Modifiers Based on Experimental Evidence ( 0 )
Disease
Interaction
References
Comments on Models/Modifiers Based on Experimental Evidence ( 0 )
 
Disease-implicated variant(s)
 
Phenotypic Data
Phenotypic Class
Phenotype Manifest In
Detailed Description
Statement
Reference

Neuromuscular junctions (NMJs) of third instar Act57BE84K mutant larvae show aberrant active zone spacing and density. Homozygous Act57BE84K larvae display reduced locomotion and growth, and rarely survive to pupation. Homozygous Act57BE84K mutants are smaller than age-matched control animals, however, total synaptic bouton number per muscle are is not significantly different from control. Total active zone number normalised to bouton number reveals a reduction compared with controls. Bouton volume is slightly increased compared with controls, indicating that the reduced number of active zones per bouton in Act57BE84K mutants is not due to a reduction in bouton volumes.

Act57BE84K/Df(2R)Exel7166 larvae show a similar lethal stage and presynaptic active zone abnormalities.

Homozygous Act57BE84K mutant larvae also exhibit changes relative to wild-type in the size and location of glutamate receptor fields.

Sarcomere and myofibril assembly is not disrupted in Act57BE84K mutants. However, aberrant actin filaments are apparent outside of the sarcomeric organisation, concentrating around the NMJ. Instead of the normal homogeneous distribution of actin surrounding boutons in control animals, Act57BE84K mutants display large actin swirls.

Act57BE84K mutant larvae display defects in localisation of postsynaptic spectrin cytoskeleton components. The organised spectrin halo structure observed in wild-type animals is largely lost, leading to aberrant localisation of the spectrin cytoskeleton in Act57BE84K mutants. These data indicate the actin-spectrin lattice at the muscle plasma membrane is disrupted in Act57BE84K mutants.

Act57BE84K mutant NMJs display a severe disruption of the postsynaptic subsynaptic reticulum (SSR) membrane folds that normally surround presynaptic boutons. Wild-type NMJs show numerous membrane folds surrounding each bouton, while Act57BE84K boutons show a smaller SSR with fewer membrane layers and a reduction in thickness. Occasionally, membrane folds are missing entirely, and regions of presynaptic membrane are seen directly abutting muscle myofibrils in Act57BE84K mutants.

Presynaptic active zones unapposed to postsynaptic glutamate receptor fields are observed in wild-type animals at a relatively low rate. In contrast, Act57BE84K mutants display frequent defects in proper active zone alignment.

Compared with wild-type, Act57BE84K/Df(2R)Exel7166 and homozygous Act57BE84K mutants display significantly decreased evoked neurotransmitter release. Measurement of spontaneous miniature event amplitude reveals a reduction in the average size of the miniature excitatory junctional potential (mEJP or mini) compared with control indicating a postsynaptic defect. Consistent with the reduction in AZ number, mini frequency is also decreased in mutant animals. Quantal content(the number of synaptic vesicles released following an action potential) is similar in wild-type and mutant animals. Consistently, ultrastructural analysis fails to reveal any differences in synaptic vesicle size between wild-type and mutant animals.

External Data
Interactions
Show genetic interaction network for Enhancers & Suppressors
Phenotypic Class
Other
Phenotype Manifest In
Additional Comments
Genetic Interactions
Statement
Reference

Quantification of active zone (AZ) apposition at third instar larval neuromuscular junctions in either heterozygote Act57BE84K/+ or Nrx-1278/+ alone reveal no significant increase in unappossed AZs compared to wild-type. However, heterozygosity for Nrx-1278 I THE Act57BE84K/+ background results in a significant increase in misaligned AZs to postsynaptic receptor fields.

Xenogenetic Interactions
Statement
Reference
Complementation and Rescue Data
Comments
Images (0)
Mutant
Wild-type
Stocks (0)
Notes on Origin
Discoverer
External Crossreferences and Linkouts ( 0 )
Synonyms and Secondary IDs (3)
Reported As
Symbol Synonym
Act57BE84K
Name Synonyms
Secondary FlyBase IDs
    References (1)